Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Soares (Brighton, United Kingdom). Homozygosity for the FCER2 gene is associated with an increased use of leukotriene receptor antagonists. 4148

Member's Comments

No comment yet.

Related content which might interest you: Cysteinyl leukotriene receptor 1 gene variation and risk of asthma Source: Eur Respir J 2009; 33: 42-48 Year: 2009 Leukotriene C4 synthase polymorphism does not associate with clinical response to leukotriene receptor antagonists in persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 303s Year: 2002 IL33 receptor activation is IL33 isoform and receptor genotype specific Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases Year: 2019 Promoter polymorphisms of cysteinyl leukotriene type 1 receptor in patients with severe asthma Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007 Expression of cysteinyl leukotriene type 1 receptor splice variants in asthmatic patients with different promoter genotypes Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008 A common intragenic marker of cysteinyl leukotrienes receptor-1 (T927C) does not correlate with a clinical response to the receptor's antagonist but is associated with peripheral blood eosinophilia Source: Eur Respir J 2001; 18: Suppl. 33, 260s Year: 2001 An association study between thromboxane A2 receptor gene T924C polymorphism and the severity of asthma in Chinese children Source: Eur Respir J 2001; 18: Suppl. 33, 451s Year: 2001 Clustering of patients with bronchial asthma with regard to the genotypes for Bcl1 polymorphism in the glucocorticoid receptor gene Source: International Congress 2017 – Gene signatures in bronchial diseases Year: 2017 Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing VEGF expression Source: Eur Respir J 2004; 24: Suppl. 48, 129s Year: 2004 Association of ER22/23EK glucocorticoid receptor gene polymorphism with glucocorticoids dosage in COPD Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Interleukin-1R antagonist gene and pre-natal smoke exposure are associated with childhood asthma Source: Eur Respir J 2007; 29: 502-508 Year: 2007 Analysis of glucocorticoid receptor gene polymorphisms in asthmatic children Source: Eur Respir J 2007; 30: Suppl. 51, 710s Year: 2007 The pro-apoptotic effect of cysteinyl leukotriene receptor (CysLT-R) antagonist montelukast is mediated by CysLT-Rs expression on antigen-stimulated T cells Source: Eur Respir J 2003; 22: Suppl. 45, 100s Year: 2003 The human leptin receptor gene Gln223Arg polymorphism and the presence of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 537s Year: 2003 Effect of leukotriene receptor antagonist on expression and variation of TGF-beta in T lymphocyte for mild persistent asthma in children Source: Annual Congress 2011 - Treating childhood asthma Year: 2011 Arg16Gly polymorphism of the β2-adrenergic receptor gene does not modulate clinical response to salmeterol in subjects with asthma Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008 Serotonin system in smoking addiction: the role of T102C polymorphism of the 5HT2A receptor gene Source: Annual Congress 2004 - Update on smoking related damage and cessation Year: 2004 The CysLT1 receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016 The dual endothelin receptor antagonist bosentan reduces TNFα induced GM-CSF release more effectively than the endothelin A receptor antagonist ambrisentan Source: Annual Congress 2010 - Airway smooth muscle cells Year: 2010 A case control study:The role of leukotriene receptor antagonist in cardiovascular risk Source: International Congress 2017 – Towards better treatments for lung disease: experimental pharmacology Year: 2017